Inspire Medical Systems, Inc. (INSP)
Automate Your Wheel Strategy on INSP
With Tiblio's Option Bot, you can configure your own wheel strategy including INSP - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol INSP
- Rev/Share 30.0903
- Book/Share 22.7209
- PB 3.1733
- Debt/Equity 0.0489
- CurrentRatio 5.2912
- ROIC 0.045
- MktCap 2132308039.0
- FreeCF/Share 3.3689
- PFCF 21.5781
- PE 47.4654
- Debt/Assets 0.0403
- DivYield 0
- ROE 0.0668
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 2
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | INSP | RBC Capital Mkts | Outperform | Sector Perform | -- | $90 | Jan. 27, 2026 |
| Downgrade | INSP | Oppenheimer | Outperform | Perform | -- | -- | Jan. 22, 2026 |
| Downgrade | INSP | Truist | Buy | Hold | -- | $96 | Jan. 22, 2026 |
| Upgrade | INSP | Oppenheimer | Perform | Outperform | -- | $175 | Dec. 8, 2025 |
| Downgrade | INSP | Morgan Stanley | Overweight | Equal Weight | -- | $130 | Dec. 2, 2025 |
| Upgrade | INSP | Truist | Hold | Buy | -- | $165 | Nov. 26, 2025 |
| Upgrade | INSP | Wolfe Research | Peer Perform | Outperform | -- | $180 | Nov. 25, 2025 |
| Upgrade | INSP | Stifel | Hold | Buy | -- | -- | Nov. 24, 2025 |
| Upgrade | INSP | Wells Fargo | Equal Weight | Overweight | -- | $90 | Nov. 4, 2025 |
| Downgrade | INSP | Jefferies | Buy | Hold | -- | $85 | Oct. 24, 2025 |
News
Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Should You Buy?
Published: February 04, 2026 by: Zacks Investment Research
Sentiment: Positive
Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: February 03, 2026 by: Zacks Investment Research
Sentiment: Positive
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Read More
Kuehn Law Encourages Investors of Inspire Medical Systems, Inc. to Contact Law Firm
Published: January 30, 2026 by: PRNewsWire
Sentiment: Neutral
NEW YORK, Jan. 30, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Inspire Medical Systems, Inc. (NYSE: INSP) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Inspire Medical caused the company to misrepresent or fail to disclose that: (1) the Inspire V launch was going poorly due to a lack of demand caused by providers holding a significant amount of surplus inventory and adoption disincentives caused by lower physician payments; (2) the launch was facing a number of critical issues because Inspire had …
Read More
Here's Why You Should Retain INSP Stock in Your Portfolio for Now
Published: January 22, 2026 by: Zacks Investment Research
Sentiment: Positive
INSP navigates a product shift as Inspire V gains traction, reimbursement improves, and management balances growth with near-term pressures.
Read More
Impulse Dynamics® Announces New Chief Financial Officer
Published: January 13, 2026 by: GlobeNewsWire
Sentiment: Neutral
MARLTON, N.J., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Impulse Dynamics®, a global medical device company committed to improving the lives of people with heart failure (HF), announced today the appointment of Richard J.
Read More
Kuehn Law Encourages Investors of Inspire Medical Systems, Inc. to Contact Law Firm
Published: January 07, 2026 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Inspire Medical Systems, Inc. (NYSE: INSP) breached their fiduciary duties to shareholders.
Read More
FINAL DEADLINE REMINDER: Faruqi & Faruqi, LLP Reminds Inspire Medical Systems Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026
Published: January 05, 2026 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)---- $INSP #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP) and reminds investors of the January 5, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and.
Read More
Bronstein, Gewirtz & Grossman LLC Urges Inspire Medical Systems, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Published: January 05, 2026 by: GlobeNewsWire
Sentiment: Neutral
New class action for Inspire Medical Systems, Inc. investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 1/5/2026
Read More
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Published: January 05, 2026 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Jan. 05, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before January 5, 2026.
Read More
INSP DEADLINE ALERT: Hagens Berman Alerts Inspire Medical Systems (INSP) Investors to Today's Lead Plaintiff Deadline in Securities Class Action
Published: January 05, 2026 by: GlobeNewsWire
Sentiment: Neutral
SAN FRANCISCO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- National investor rights law firm Hagens Berman alerts INSP investors to the pending securities class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP). The firm is urging INSP investors who suffered substantial losses to contact attorneys before the January 5, 2026, Lead Plaintiff Deadline.
Read More
INSP 3-DAY DEADLINE ALERT: $42.04 Stock Drop at Inspire Medical Systems (INSP) Triggers Securities Fraud Lawsuit Over Concealed Medicare Billing Software Failures & Inspire V Inventory Glut
Published: January 02, 2026 by: GlobeNewsWire
Sentiment: Neutral
Partner Reed Kathrein Urges Investors to Contact Firm Before January 5, 2026 Lead Plaintiff Deadline Partner Reed Kathrein Urges Investors to Contact Firm Before January 5, 2026 Lead Plaintiff Deadline
Read More
Deadline Soon: Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
Published: January 02, 2026 by: Business Wire
Sentiment: Neutral
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming January 5, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON INSPIRE MEDICAL SYSTEMS, INC. (INSP), CLICK HERE TO PA.
Read More
INSPIRE MEDICAL URGENT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inspire Medical Systems, Inc. and Encourages Investors to Contact the Firm
Published: January 02, 2026 by: GlobeNewsWire
Sentiment: Neutral
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Inspire Medical (INSP) To Contact Him Directly To Discuss Their Options If you purchased or acquired Inspire common stock between August 6, 2024 through August 4, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648.
Read More
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Inspire Medical Systems Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026
Published: January 02, 2026 by: GlobeNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options
Read More
INSP STOCK DROP: Inspire Medical Systems, Inc. Stock Plummets 32% after Inspire V Delays Disclosed -- Contact BFA Law about the Securities Fraud Class Action
Published: January 02, 2026 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/inspire-medical-systems-inc-class-action-lawsuit.
Read More
Investors in Inspire Medical Systems, Inc. Should Contact Levi & Korsinsky Before January 5, 2026 to Discuss Your Rights - INSP
Published: January 02, 2026 by: PRNewsWire
Sentiment: Neutral
NEW YORK, Jan. 2, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Inspire Medical Systems, Inc. ("Inspire Medical Systems, Inc." or the "Company") (NYSE: INSP) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Inspire Medical Systems, Inc. investors who were adversely affected by alleged securities fraud between August 6, 2024 and August 4, 2025.
Read More
Bronstein, Gewirtz & Grossman LLC Urges Inspire Medical Systems, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Published: January 01, 2026 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Jan. 01, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Inspire securities between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”).
Read More
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Published: January 01, 2026 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Jan. 01, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before January 5, 2026.
Read More
5-DAY DEADLINE ALERT: $42.04 Stock Drop at Inspire Medical Systems (INSP) Triggers Securities Fraud Lawsuit Over Concealed Medicare Billing Software Failures & Inspire V Inventory Glut
Published: January 01, 2026 by: PRNewsWire
Sentiment: Neutral
Partner Reed Kathrein Urges Investors to Contact Firm Before January 5, 2026 Lead Plaintiff Deadline SAN FRANCISCO, Jan. 1, 2026 /PRNewswire/ -- National investor rights law firm Hagens Berman alerts INSP investors to the pending securities class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP). The firm is urging INSP investors who suffered substantial losses to contact its attorneys before the January 5, 2026, Lead Plaintiff Deadline.
Read More
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Inspire Medical Systems Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026
Published: January 01, 2026 by: PRNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Inspire Medical between August 6, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Jan. 1, 2026 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical Systems, Inc. ("Inspire …
Read More
INSP COURT NOTICE: Inspire Medical Systems, Inc. Investors are Encouraged to Contact BFA Law About the Securities Fraud Class Action by January 5
Published: December 31, 2025 by: Newsfile Corp
Sentiment: Neutral
New York, New York--(Newsfile Corp. - December 31, 2025) - Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/inspire-medical-systems-inc-class-action-lawsuit.
Read More
INSP Deadline: INSP Investors with Losses in Excess of $100K Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit
Published: December 31, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK, Dec. 31, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class Period"), of the important January 5, 2026 lead plaintiff deadline. So what: If you purchased Inspire Medical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Read More
INSP DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important January 5 Deadline in Securities Class Action - INSP
Published: December 31, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), of the important January 5, 2026 lead plaintiff deadline.
Read More
INSP CLASS ACTION DEADLINE: $42.04 Stock Drop at Inspire Medical Systems (INSP) Triggers Securities Fraud Lawsuit Over Concealed Medicare Billing Software Failures & Inspire V Inventory Glut
Published: December 31, 2025 by: GlobeNewsWire
Sentiment: Neutral
Partner Reed Kathrein Urges Investors to Contact Firm Before January 5, 2026 Lead Plaintiff Deadline Partner Reed Kathrein Urges Investors to Contact Firm Before January 5, 2026 Lead Plaintiff Deadline
Read More
Kuehn Law Encourages Investors of Inspire Medical Systems, Inc. to Contact Law Firm
Published: December 31, 2025 by: Newsfile Corp
Sentiment: Neutral
New York, New York--(Newsfile Corp. - December 31, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Inspire Medical Systems, Inc. (NYSE: INSP) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Inspire Medical caused the company to misrepresent or fail to disclose that: (1) the Inspire V launch was going poorly due to a lack of demand caused by providers holding a significant amount of surplus inventory and adoption disincentives caused by lower physician payments; (2) the launch was facing a number of critical issues …
Read More
INSP SHAREHOLDER UPDATE: Inspire Medical Systems, Inc. Hit with Securities Class Action after 32% Stock Drop – Contact BFA Law if You Lost Money
Published: December 31, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/inspire-medical-systems-inc-class-action-lawsuit.
Read More
INSP CLASS ACTION ALERT: Inspire Medical Systems, Inc. Sued for Securities Fraud after Product Delays, Investors Notified to Contact BFA Law by January 5
Published: December 30, 2025 by: Newsfile Corp
Sentiment: Neutral
New York, New York--(Newsfile Corp. - December 30, 2025) - Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/inspire-medical-systems-inc-class-action-lawsuit.
Read More
Deadline Alert: Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Published: December 30, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming January 5, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR INSPIRE INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.
Read More
Portnoy Law Firm Announces Class Action on Behalf of Inspire Medical Investors
Published: December 30, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Inspire Medical (“Inspire” or the "Company") (NYSE: INSP) investors of a class action on behalf of investors that bought securities between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”). Inspire investors have until January 5, 2026 to file a lead plaintiff motion.
Read More
INVESTOR ALERT: Inspire Medical Systems, Inc. (INSP) Investors are Notified to Contact BFA Law about the Pending Securities Fraud Class Action by January 5 Deadline
Published: December 29, 2025 by: Newsfile Corp
Sentiment: Neutral
New York, New York--(Newsfile Corp. - December 29, 2025) - Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/inspire-medical-systems-inc-class-action-lawsuit.
Read More
About Inspire Medical Systems, Inc. (INSP)
- IPO Date 2018-05-03
- Website https://www.inspiresleep.com
- Industry Medical - Devices
- CEO Timothy Herbert
- Employees 1246